NovaBay Pharmaceuticals, Inc. Common Stock (NBY)

Last Price1.1600

Change-0.0600 (-4.92%)

NYSE · Last Trade: Mar 22nd, 6:47 PM EDT

Detailed Quote

Previous Close	1.220
Open	1.220
Bid	1.140
Ask	1.230
Day's Range	1.160 - 1.250
52 Week Range	1.110 - 99.75
Volume	132,575
Market Cap	34.91M
PE Ratio (TTM)	1.333
EPS (TTM)	0.9
Dividend & Yield	4.000 (344.83%)
1 Month Average Volume	720,047

About NovaBay Pharmaceuticals, Inc. Common Stock (NBY)

NovaBay Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative products for the eye care and dermatology markets. The company leverages its proprietary technology platform to create and market treatments that address unmet medical needs, primarily targeting infections and conditions that affect skin and eye health. NovaBay's product pipeline includes a range of topical antimicrobial and anti-inflammatory solutions, aiming to provide effective and safe alternatives for patients and healthcare professionals. Through its commitment to research and development, NovaBay seeks to enhance the quality of care and improve patient outcomes in various therapeutic areas. Read More

NovaBay Pharmaceuticals, Inc. Common Stock (NBY)

Detailed Quote

Chart

About NovaBay Pharmaceuticals, Inc. Common Stock (NBY)

News & Press Releases